Rating History for Karyopharm Therapeutics (KPTI) by Rodman & Renshaw

More Stocks Rated by Rodman & Renshaw | Latest Ratings for KPTI
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/9/2026 Michael King Jr. New Coverage Buy
(N/A)		 28.00
(N/A)		 8.77
(9.51)		 8.44% Details